Proficio Capital Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,399
Closed -$284K 267
2025
Q4
$284K Sell
11,399
-93
-0.8% -$2.35K 0.02% 205
2025
Q3
$293K Sell
11,492
-7,684
-40% -$190K 0.02% 179
2025
Q2
$465K Sell
19,176
-3,249
-14% -$75.8K 0.03% 260
2025
Q1
$568K Buy
22,425
+13,922
+164% +$364K 0.04% 195
2024
Q4
$226K Sell
8,503
-1,334
-14% -$36.2K 0.02% 317
2024
Q3
$285K Buy
9,837
+298
+3% +$8.69K 0.03% 223
2024
Q2
$267K Sell
9,539
-332
-3% -$9.14K 0.03% 265
2024
Q1
$274K Sell
9,871
-1,346
-12% -$37.3K 0.03% 265
2023
Q4
$323K Sell
11,217
-21,617
-66% -$653K 0.04% 211
2023
Q3
$1.09M Buy
32,834
+562
+2% +$19.9K 0.15% 85
2023
Q2
$1.18M Sell
32,272
-2,423
-7% -$94.3K 0.16% 81
2023
Q1
$1.42M Sell
34,695
-1,688
-5% -$72.9K 0.22% 65
2022
Q4
$1.86M Buy
36,383
+1,953
+6% +$93.6K 0.35% 45
2022
Q3
$1.5M Sell
34,430
-1,360
-4% -$66.1K 0.28% 54
2022
Q2
$1.88M Buy
35,790
+690
+2% +$35.2K 0.35% 47
2022
Q1
$1.82M Buy
35,100
+628
+2% +$32.6K 0.27% 60
2021
Q4
$2.04M Sell
34,472
-492
-1% -$24.4K 0.28% 66
2021
Q3
$1.5M Sell
34,964
-1,298
-4% -$57.5K 0.2% 80
2021
Q2
$1.42M Buy
36,262
+894
+3% +$34.8K 0.17% 79
2021
Q1
$1.28M Buy
35,368
+8,143
+30% +$289K 0.17% 81
2020
Q4
$1M Sell
27,225
-2,887
-10% -$106K 0.16% 72
2020
Q3
$1.02M Buy
30,112
+20,632
+218% +$723K 0.18% 65
2020
Q2
$295K Sell
9,480
-3,207
-25% -$109K 0.06% 128
2020
Q1
$328K Buy
12,687
+1,555
+14% +$53K 0.08% 103
2019
Q4
$414K Buy
11,132
+2,149
+24% +$76.5K 0.12% 91
2019
Q3
$306K Sell
8,983
-4,969
-36% -$181K 0.11% 96
2019
Q2
$573K Buy
13,952
+3,918
+39% +$156K 0.2% 74
2019
Q1
$404K Buy
10,034
+3,691
+58% +$148K 0.14% 87
2018
Q4
$263K Buy
6,343
+315
+5% +$13.1K 0.12% 92
2018
Q3
$252K Sell
6,028
-281
-4% -$10.8K 0.08% 110
2018
Q2
$217K Buy
6,309
+62
+1% +$2.12K 0.09% 122
2018
Q1
$210K Buy
6,247
+120
+2% +$4.13K 0.06% 124
2017
Q4
$211K Buy
6,127
+120
+2% +$4.09K 0.07% 121
2017
Q3
$203K Sell
6,007
-17,646
-75% -$567K 0.08% 158
2017
Q2
$739K Sell
23,653
-8,209
-26% -$259K 0.31% 67
2017
Q1
$969K Sell
31,862
-4,242
-12% -$134K 0.42% 59
2016
Q4
$1.11M Sell
36,104
-769
-2% -$23.5K 0.47% 44
2016
Q3
$1.19M Hold
36,873
0.68% 40
2016
Q2
$1.28M Sell
36,873
-29,678
-45% -$947K 0.8% 33
2016
Q1
$1.87M Sell
66,551
-670
-1% -$19.1K 1.56% 11
2015
Q4
$2.06M Buy
+67,221
New +$2.11M 2.02% 9

Other funds holding PFE

Proficio Capital Partners's PFE Position: Q1 2026 in Review

Proficio Capital Partners sold out of Pfizer (PFE) in Q1 2026, closing a stake of 11,399 shares — an estimated $284K sold.

Proficio Capital Partners first reported a position in PFE in Q4 2015 and held it in 41 quarters. The position peaked at $2.06M in Q4 2015. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Proficio Capital Partners reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Proficio Capital Partners sold 11,399 Pfizer shares in Q1 2026, an estimated $284K.
  • Proficio Capital Partners first reported a position in Pfizer in Q4 2015 and held it in 41 quarters.
  • Proficio Capital Partners's Pfizer position peaked at $2.06M in Q4 2015.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Proficio Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.